These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 12232845)

  • 41. HIV related and non-HIV related mortality before and after the introduction of highly active antiretroviral therapy (HAART) in Norway compared to the general population.
    Ormaasen V; Sandvik L; Dudman SG; Bruun JN
    Scand J Infect Dis; 2007; 39(1):51-7. PubMed ID: 17366013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
    Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
    J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Opportunistic diseases--current aspects in 2004].
    Marquardt T; Jablonowski H
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():34-6, 38. PubMed ID: 15373044
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy.
    Tedaldi EM; Baker RK; Moorman AC; Alzola CF; Furhrer J; McCabe RE; Wood KC; Holmberg SD;
    Clin Infect Dis; 2003 Feb; 36(3):363-7. PubMed ID: 12539079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS.
    Hessol NA; Pipkin S; Schwarcz S; Cress RD; Bacchetti P; Scheer S
    Am J Epidemiol; 2007 May; 165(10):1143-53. PubMed ID: 17344204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer.
    Simmons RD; Ciancio BC; Kall MM; Rice BD; Delpech VC
    HIV Med; 2013 Nov; 14(10):596-604. PubMed ID: 23672663
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.
    Krentz HB; Kliewer G; Gill MJ
    HIV Med; 2005 Mar; 6(2):99-106. PubMed ID: 15807715
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality.
    Vittinghoff E; Scheer S; O'Malley P; Colfax G; Holmberg SD; Buchbinder SP
    J Infect Dis; 1999 Mar; 179(3):717-20. PubMed ID: 9952385
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of changing autopsy trends in the Bronx population with acquired immunodeficiency syndrome.
    Concepcion L; Markowitz GS; Borczuk AC; Factor SM
    Mod Pathol; 1996 Oct; 9(10):1001-6. PubMed ID: 8902838
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AIDS morbidity and mortality in Brazilian children before and after highly active antiretroviral treatment implementation: an assessment of regional trends.
    Ramos AN; Matida LH; Hearst N; Heukelbach J
    Pediatr Infect Dis J; 2011 Sep; 30(9):773-7. PubMed ID: 21502903
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Causes of death in HIV-infected women: persistent role of AIDS. The 'Mortalité 2000 & 2005' Surveys (ANRS EN19).
    Hessamfar-Bonarek M; Morlat P; Salmon D; Cacoub P; May T; Bonnet F; Rosenthal E; Costagliola D; Lewden C; Chêne G;
    Int J Epidemiol; 2010 Feb; 39(1):135-46. PubMed ID: 19805489
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mortality in Brazilian children with HIV/AIDS: the role of non-AIDS-related conditions after highly active antiretroviral therapy introduction.
    Ramos AN; Matida LH; Hearst N; Heukelbach J
    AIDS Patient Care STDS; 2011 Dec; 25(12):713-8. PubMed ID: 21688987
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Declining incidence of AIDS-defining opportunistic illnesses: results from 16 years of population-based AIDS surveillance.
    Schwarcz L; Chen MJ; Vittinghoff E; Hsu L; Schwarcz S
    AIDS; 2013 Feb; 27(4):597-605. PubMed ID: 23079812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update: trends in AIDS incidence -- United States, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Sep; 46(37):861-7. PubMed ID: 9310209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City.
    Sackoff JE; Hanna DB; Pfeiffer MR; Torian LV
    Ann Intern Med; 2006 Sep; 145(6):397-406. PubMed ID: 16983127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.
    Marin B; Thiébaut R; Bucher HC; Rondeau V; Costagliola D; Dorrucci M; Hamouda O; Prins M; Walker S; Porter K; Sabin C; Chêne G
    AIDS; 2009 Aug; 23(13):1743-53. PubMed ID: 19571723
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Specific causes of death among 381 AIDS patients who died in hospitals].
    Feng RF; Ma Y; Liu ZF; Zhang FJ; Yang Y; Huang SB; He HL; Lu J; Lei SY; Zhao HX; Dai LL; He Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Dec; 34(12):1237-41. PubMed ID: 24518028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of HAART on causes of death of persons with late-stage AIDS.
    Sansone GR; Frengley JD
    J Urban Health; 2000 Jun; 77(2):166-75. PubMed ID: 10855998
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group.
    Hajjeh RA; Conn LA; Stephens DS; Baughman W; Hamill R; Graviss E; Pappas PG; Thomas C; Reingold A; Rothrock G; Hutwagner LC; Schuchat A; Brandt ME; Pinner RW
    J Infect Dis; 1999 Feb; 179(2):449-54. PubMed ID: 9878030
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy).
    Farmer P; Léandre F; Mukherjee J; Gupta R; Tarter L; Kim JY
    Bull World Health Organ; 2001; 79(12):1145-51. PubMed ID: 11799447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.